20 likes | 33 Views
Increasing number of genetic disorders to propel the market growth<br>The global genotyping assay market is propelled by a number of factors. One among them is the increase in the number of genetic diseases all around the world. Following that is the general awareness regarding personalized medicine all around the world especially in the developed regions of the world. According to the Parkinsonu2019s Foundation, more than 60 thousand people are diagnosed with the major genetic disorder, Parkinsonu2019s disease in the U.S. every year. Moreover, the number is expected to reach 1 million by 2020<br>Read More: https://www.marketindustryreports.com/genotyping-assay-market/7<br>
E N D